Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoglobulin Light-chain Amyloidosis × nelarabine × Clear all

Sponsor

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, T-Cell 1 Leukemia, B-Cell 1 Leukemia 1

Interventions

Dexamethasone 15 Melphalan 13 Bortezomib 10 Calcium Dobesilate 7 Filgrastim 6 Granulocyte Colony-Stimulating Factor 5 birtamimab 4 Cyclophosphamide 4 dexamethasone acetate 3 Thalidomide 3 Peripheral Blood Stem Cell Transplantation 3 Lenalidomide 3 fludarabine phosphate 2 daratumumab 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 Doxycycline 2 Darbepoetin alfa 2 Cyclosporine 2 Blood Component Removal 2 pomalidomide 1 pegfilgrastim 1 isatuximab 1 ferrous sulfate 1 ferric gluconate 1 dexamethasone 21-phosphate 1 carfilzomib 1 Therapeutics 1 Surveys and Questionnaires 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡